{
  "docId": "019de076-794e-71d3-9fbb-8ba3f121f554",
  "docSlug": "4ee48ed5e56c8ddc8f74aa05772c7ac4",
  "documentTitle": "Comera | Investor Presentation Deck | 16 slides",
  "authorId": "comera",
  "authorName": "Comera",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-12-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.2938006,
  "pageNumber": 4,
  "pageCount": 16,
  "prevPage": 3,
  "nextPage": 5,
  "slideType": "problem_statement",
  "function": "frame_problem",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "Uses a visual metaphor of fluid dynamics (beakers and spheres) to explain viscosity reduction.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-794e-71d3-9fbb-8ba3f121f554/4",
  "deckHref": "/decks/019de076-794e-71d3-9fbb-8ba3f121f554",
  "deckJsonHref": "/decks/019de076-794e-71d3-9fbb-8ba3f121f554.json",
  "deckAnchorHref": "/decks/019de076-794e-71d3-9fbb-8ba3f121f554#slide-4",
  "components": [
    {
      "bbox": {
        "h": 0.4,
        "w": 0.354,
        "x": 0.605,
        "y": 0.333
      },
      "kind": "callout",
      "text": "Lack of innovation highlighted by FDA Novel Excipient Review Pilot Program",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "75c0852d-da3d-4405-9239-05cf5a43e369",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.58,
        "x": 0.04,
        "y": 0.39
      },
      "kind": "image",
      "text": "Visual comparison of high vs low viscosity using beakers and molecular spheres",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c653f921-c010-42cf-ba02-33cc97e41c85",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.26,
        "x": 0.04,
        "y": 0.7
      },
      "kind": "paragraph",
      "text": "High Viscosity: Results from high protein concentration and limits IV to SQ conversion",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7322603d-6e1d-41c9-8443-9d5419a9cf9c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.26,
        "x": 0.31,
        "y": 0.73
      },
      "kind": "paragraph",
      "text": "Low Viscosity: SQore technology enables IV to SQ conversion by reducing viscosity",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "93f69ce0-9562-4b3f-91f8-24e823a72c21",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.48,
        "x": 0.04,
        "y": 0.285
      },
      "kind": "title",
      "text": "High Viscosity a Significant Hurdle to Formulating SQ Biologics",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9a8cbcb2-bf2d-4058-842a-5c4d1cc63cd8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.72,
        "x": 0.04,
        "y": 0.16
      },
      "kind": "title",
      "text": "Formulating SQ Biologics is Technically Challenging, Without Much Innovation by Pharma in this Space",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5d7dcb58-a899-495a-a745-b16c5e1edfb7",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "before-after-framing",
      "slug": null,
      "matchId": "d3851cc7-e8fe-475c-b509-446531cf7833",
      "evidence": "Visual comparison of high viscosity (problem) vs low viscosity (solution via SQore)",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 4,
      "from": 4,
      "beatId": "384e17c3-89b0-4091-b4da-62d609051a42",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Problem",
      "beatSlug": "problem-agitate-solution-problem-identify-pain",
      "evidence": "The deck identifies high viscosity as a significant hurdle to formulating SQ biologics.",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 5,
      "from": 4,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "a5636b4e-112e-4564-9431-0fcd37749050",
      "evidence": "The deck presents the problem statement and solution, implying the cost of inaction.",
      "position": 0,
      "objective": "What are the consequences of not addressing high viscosity in SQ biologics?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}